Newsroom | 5239 results

BEAUFORT, S.C.--(BUSINESS WIRE)--Since 1995, the number of U.S. citizens with PAD has approximately doubled from 11 million to over 22 million. PAD is extremely costly with a current economic burden of $352-$694 billion, accounting for 7%-13% of National Health Expenditures.“Although PAD prevalence exceeds that of heart disease and stroke, compared to these other cardiovascular diseases, PAD remains underappreciated. PAD is a significant source of morbidity and mortality, as well as a major caus...

WOOD DALE, Ill.--(BUSINESS WIRE)--PHC Corporation of North America (PHCNA), provider of PHCbi cell culture and sample preservation solutions across North America and Latin America, has introduced a new series of laboratory incubators featuring active hybrid humidification technology and enhanced contamination control. The new Cell-IQ® CO₂ incubator line is designed to deliver improved environmental stability for a wide range of cell culture applications. Maintaining precise and stable incubatio...

NEW YORK--(BUSINESS WIRE)--Cambrian Bio presents positive Phase 1b data for ATX-304, the first AMPK Network Activator, at the ADA's 86th Scientific Sessions....

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced its plan to host a 2026 Summer Series of R&D webinars that highlight multiple clinical stage RNA interference (RNAi) based medicines that utilize the company’s proprietary Targeted RNAi Molecule (TRiM™) platform. Each webinar in the Summer Series will focus on a specific therapeutic area and will feature presentations by Arrowhead team members about the company’s clinical candidates and externa...

MILAN--(BUSINESS WIRE)--WISE S.p.A., a pioneering medical device company specializing in advanced implantable electrodes for neuromonitoring, neuromodulation, and brain-computer interface (BCI), today announced the successful closing of an oversubscribed Series D financing round totaling €30 million. The round was joined by ENEA Tech and Biomedical, an Italian foundation dedicated to innovation and technology transfer in the biomedical sector, which enters WISE's investor base as a strategic pa...

BERLIN--(BUSINESS WIRE)--Bayer today announced the completion of the acquisition of Perfuse Therapeutics, Inc. As a result, Perfuse Therapeutics will now be fully integrated into Bayer. As announced previously, Bayer now holds the full rights pertaining to PER-001 intravitreal implant, a first in class, sustained release small molecule endothelin receptor antagonist currently in Phase II clinical development for the treatment of Glaucoma and Diabetic Retinopathy (DR). This acquisition strengthe...

DENVER--(BUSINESS WIRE)--Virta Health, the leader in metabolic disease reversal, today released its third annual 2026 Virta Vitals, a national survey of U.S. adults that examines Americans' evolving attitudes and behaviors toward GLP-1 medications. While GLP-1 medications have become one of the most visible health trends in America, this year’s report found that less than a third (31%) of current and former GLP-1 users are likely to admit to using one, revealing a surprising gap between public...

DENVER--(BUSINESS WIRE)--Strive Health, the national leader in value-based kidney care, has welcomed two new members to its executive team. Jamie Sharp, M.D., has been named chief medical officer and will oversee Strive’s clinical strategy and performance. Serving as chief financial officer, Chris Rigg will drive financial strategy and operations, while helping scale the business and deploy AI technologies.“As we continue to build on Strive’s strong momentum, Jamie and Chris stood out as the rig...

TORONTO & NEW YORK--(BUSINESS WIRE)--Researchers at Klick Labs are launching a series of clinical studies with Mayo Clinic in Florida exploring the use of novel vocal biomarkers....

MENLO PARK, Calif.--(BUSINESS WIRE)--OrsoBio presents positive Phase 2a data for its LXR inverse agonist TLC-2716 in SHTG and MASLD at ENDO 2026....